Lack of a point mutation of human DNA topoisomerase II in multidrug-resistant anaplastic thyroid carcinoma cell lines

Cancer Letters

Volumn 116, Issue 1, 1997, Pages 33-39

  Satake, Shoji ^a   Sugawara, Isamu ^b   Watanabe, Masatoshi ^b   Takami, Hiroshi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Anaplastic carcinoma; DNA topoisomerase II ; Multidrug resistance; Thyroid

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; MITOXANTRONE; VINCRISTINE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; DRUG CYTOTOXICITY; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MULTIDRUG RESISTANCE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA;

AGED; BLEOMYCIN; BLOTTING, WESTERN; CARCINOMA; CISPLATIN; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; P-GLYCOPROTEIN; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES; VINCRISTINE;

EID: 0030961232     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04742-3     Document Type: Article

References (24)

1. Arai, T., Watanabe, M., Onodera, M., Yamashita, T., Masunaga, A., Itoyama, S., Itoh, K. and Sugawara, I. (1993) Reduced nm23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid, Am. J. Pathol., 142, 1938-1944.
2. Beck, W.T. and Danks, M.K. (1991) Mechanisms of resistance to drugs that inhibit DNA topoisomerases, Semin. Cancer Biol., 2, 235-244.
3. Bugg, B., Danks, M.K., Beck, W.T. and Suttle, D.P. (1991) Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemia cells selected for resistance to teniposide, Proc. Natl. Acad. Sci. USA, 88, 7654-7658.
4. Danks, M.K., Warmouth, M.R., Friche, E., Granzen, B., Bugg, B.Y., Harker, W.G., Zwelling, L.A., Futcher, B.W., Suttle, D.P. and Beck, W.T. (1993) Single-strand conformation polymorphism analysis of the Mr 170,000 isozyme of DNA topoisomerase II in human tumor cells, Cancer Res., 53, 1373-1379.
5. D'Arpa, P. and Liu, L.F. (1989) Topoisomerase-targeting antitumor drugs, Biochim. Biophys. Acta, 989, 163-177.
6. Drake, F.H., Hofmann, G.H., Mong, S.H., Bartus, J.O., Hertzberg, R.P., Johnson, R.K., Mattern, M.R. and Mirabelli, C.K. (1989) In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone, Cancer Res., 49, 2578-2583.
7. Guild, B.C., Mulligan, R.C., Gros, P. and Housman, D.E. (1988) Retroviral transfer of a murine cDNA for drug resistance confers pleiotropic resistance to cells without prior drug selection. Proc. Natl. Acad. Sci. USA, 85, 1595-1599.
8. Heck, M.M.S. and Earnshaw, W.E. (1986) Topoisomerase II: a specific marker for cell proliferation, J. Cell Biol., 103, 2569-2581.
9. Hsing, Y., Jannatipour, M., Rose, A., McMahon, J., Duncan, D. and Nitiss, J.L. (1996) Functional expression of human topoisomerase IIα in yeast: mutations at amino acids 450 or 803 of topoisomerase IIα result in enzymes that can confer resistance to anti-topoisomerase II agents, Cancer Res., 56, 91-99.
10. Huang, W. (1990) Nucleotide sequences and the encoded amino acids of DNA topoisomerase genes. In: DNA Topology and its Biological Effects, pp. 265-284. Editors: N.R. Cozzarelli and J.C. Wang. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
11. Hsu, S.M., Raine, L. and Fanger, H. (1981) Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577-580.
12. Nel, C.J.C. and van Heerden, J.A. (1985) Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases, Mayo Clin. Proc., 60, 51-58.
13. Nitiss, J.L., Vilalta, P.M., Wu, H. and McMahon, J. (1994) Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine. Mol. Pharmacol., 46, 773-777.
14. Pommier, Y. (1993) DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemother. Pharmacol., 32, 103-108.
15. Scheper, R.J., Broxterman, H.J., Scheffer, G.L., Kaaijk, P., Dalton, W., van Heijningen, T.H.M., van Kalken, C.K., Slovak, M.L., de Vries, E.G.E., van der Valk, P., Meijer, C.J.L.M. and Pinedo, H.M. (1993) Overexpression of a Mr 110,000 visicular protein in non-P-glycoprotein-mediated multidrug resistance, Cancer Res., 53, 1475-1479.
16. Sugawara, I., Iwahashi, T., Okamoto, K., Sugimoto, Y., Ekimoto, H., Tsuruo, T., Ikeuchi, T. and Mori, S. (1991) Characterization of an etoposide-resistant human K562 cell line, K/eto. Jpn. J. Cancer Res., 82, 1035-1043.
17. Sugawara, I., Hirata, A., Ueda, K. and Itoyama, S. (1992) Preparation and characterization of a murine monoclonal antibody (MDR3M) reactive with mdr3 gene product, Jpn. J. Cancer Res., 83, 795-797.
18. Sugawara, I., Arai, T., Yamashita, T., Yoshida, A., Masunaga, A. and Itoyama, S. (1994) Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid, Cancer Lett., 82, 185-188.
19. Sugawara, I., Masunaga, A., Itoyama, S., Sumizawa, T., Akiyama, S. and Yamashita, T. (1995) Expression of multidrug resistance-associated protein (MRP) in thyroid cancers, Cancer Lett., 95, 135-138.
20. Sugawara, I., Watanabe, M., Yamashita, T., Yoshida, A., Itoh, K. and Itoyama, S. (1995) Multiple anti-cancer drug resistance observed in untreated anaplastic thyroid carcinoma cell lines, Tumor Targeting, 1, 93-98.
21. Sugawara, I., Akiyama, S., Scheper, R.J. and Itoyama, S. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett., in press.
22. Sumizawa, T., Chuma, Y., Sakamoto, H., Iemura, K., Almquist, K.C., Deeley, R.G., Cole, S.P.C. and Akiyama, S. (1994) Non-P-glycoprotein mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine and mezerein, Somat. Cell Mol. Genet., 20, 423-435.
23. Tsuruo, T., Iida-Saito, H., Kawabata, H., Oh-hara, T., Hamada, H. and Utakoji, T. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn. J. Cancer Res., 77, 682-692.
24. Yamashita, T., Watanabe, M., Onodera, M., Shimaoka, K., Ito, K., Fujimoto, Y., Itoyama, S. and Sugawara, I. (1994) Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid, Cancer Detect. Prev., 18, 407-413.